Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care

A Tsakris1, A Ikonomidis, A Poulou

  • 1Department of Microbiology, Medical School, University of Athens, Athens, Greece. atsakris@med.uoa.gr

Insights

Multidrug-resistant Acinetobacter baumannii strains carrying carbapenemase genes caused severe infections in a Greek hospital. This study highlights the clonal spread of these resistant bacteria and their impact on patient mortality.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Genetics

Background:

  • Acinetobacter baumannii is a significant cause of hospital-acquired infections, particularly in intensive care units (ICUs).
  • The emergence of carbapenem resistance in A. baumannii poses a major threat to patient treatment and outcomes.
  • Understanding the genetic basis and clonal dissemination of resistant strains is crucial for infection control.

Purpose of the Study:

  • To investigate the characteristics of imipenem-resistant Acinetobacter baumannii isolates from ICU patients in a Greek hospital.
  • To identify the carbapenemase genes and clonal types involved in infections and colonizations.
  • To determine the genetic location and spread of resistance determinants.

Main Methods:

  • Surveillance of ICU patients over a 2-year period for imipenem-resistant A. baumannii.
  • Molecular typing to identify distinct clones.
  • Detection and characterization of carbapenemase genes (blaVIM, blaOXA) using PCR, curing, and hybridization.
  • Analysis of insertion sequences (ISAba1, ISAba3) associated with resistance genes.

Main Results:

  • Thirty-one imipenem-resistant A. baumannii isolates were identified, with 7 patient deaths attributed to infection.
  • Isolates belonged to four distinct multidrug-resistant clones.
  • Different carbapenemase genes (blaVIM-1, blaVIM-4, blaOXA-58) were found in different clones.
  • blaVIM genes were chromosomally located, while blaOXA-58 genes were plasmid-located.

Conclusions:

  • This study is the first to describe the clonal spread of multidrug-resistant A. baumannii carrying blaVIM-1 and blaVIM-4.
  • Distinct carbapenem-resistant A. baumannii clones with varying carbapenemase genes can emerge and cause severe infections.
  • Effective infection control strategies are essential to manage the spread of carbapenem-resistant A. baumannii in healthcare settings.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...